The current valuation score of Amneal Pharmaceuticals Inc is 9.30, ranking 30 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 41.81, which is 2328.76% below the recent high of 1015.40 and 1073.31% above the recent low of -406.91.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.